Literature DB >> 26889486

The impact of sedation protocols on outcomes in critical illness.

Benjamin Scott1, Tobias Eckle1.   

Abstract

Year:  2016        PMID: 26889486      PMCID: PMC4731598          DOI: 10.3978/j.issn.2305-5839.2015.12.47

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  20 in total

1.  Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit.

Authors:  Guttorm Brattebø; Dag Hofoss; Hans Flaatten; Anne Kristine Muri; Stig Gjerde; Paul E Plsek
Journal:  BMJ       Date:  2002-06-08

2.  Mitochondrial dysfunction and resuscitation in sepsis.

Authors:  Albert J Ruggieri; Richard J Levy; Clifford S Deutschman
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Editorial: Health Impact and Management of a Disrupted Circadian Rhythm and Sleep in Critical Illnesses.

Authors:  Tobias Eckle
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 4.  Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation.

Authors:  Lisa Burry; Louise Rose; Iain J McCullagh; Dean A Fergusson; Niall D Ferguson; Sangeeta Mehta
Journal:  Cochrane Database Syst Rev       Date:  2014-07-09

5.  Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

Authors:  Stephan M Jakob; Esko Ruokonen; R Michael Grounds; Toni Sarapohja; Chris Garratt; Stuart J Pocock; J Raymond Bratty; Jukka Takala
Journal:  JAMA       Date:  2012-03-21       Impact factor: 56.272

6.  A circadian gene expression atlas in mammals: implications for biology and medicine.

Authors:  Ray Zhang; Nicholas F Lahens; Heather I Ballance; Michael E Hughes; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

Review 7.  Circadian Rhythm Disruption in the Critically Ill: An Opportunity for Improving Outcomes.

Authors:  Mark A Oldham; Hochang B Lee; Paul H Desan
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

8.  Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial.

Authors:  Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

Review 9.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

Review 10.  Defining the Role of Dexmedetomidine in the Prevention of Delirium in the Intensive Care Unit.

Authors:  S Nelson; A J Muzyk; M H Bucklin; S Brudney; J P Gagliardi
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

View more
  2 in total

1.  A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction.

Authors:  Jennifer Gile; Yoshimasa Oyama; Sydney Shuff; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

2.  The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium.

Authors:  Jennifer Gile; Benjamin Scott; Tobias Eckle
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.